Revvity Files Second-Quarter 10-Q as Investor Conference Season Approaches
The life sciences and diagnostics company submitted its quarterly report to regulators, with management set to appear at major healthcare investor events in September.
Quarterly Filing Submitted
Revvity, Inc. (RVTY) filed its quarterly report on Form 10-Q with the Securities and Exchange Commission on August 11, according to SEC EDGAR filings. The Waltham, Massachusetts-based life sciences and diagnostics company, which carries a market capitalization of approximately $13 billion, submitted the routine regulatory disclosure covering its most recent fiscal quarter.
The company's shares closed at $116.02 in their most recent trading session.
Upcoming Investor Engagements
Revvity management is scheduled to participate in two prominent healthcare investor conferences in September, according to MarginX data. The company will present at the Wells Fargo 21st Annual Healthcare Conference on September 9 at 8:45 AM, followed by an appearance at the Morgan Stanley 24th Annual Global Healthcare Conference on September 14 at 8:30 AM.
The Wells Fargo event is set for September 8, while the Morgan Stanley conference runs from September 14 through September 16. These forums typically provide opportunities for management to discuss strategic priorities and field questions from institutional investors and analysts.
Recent Insider Activity
MarginX data shows recent insider transactions at the company. Anita Gonzales sold 85 shares and had 33 shares withheld for tax purposes, while Pascale Witz received an award of 1,265 shares. Such equity-based awards are common components of executive compensation packages at publicly traded companies.
Company Profile
Revvity operates in the life sciences and diagnostics sectors, providing technologies and services to researchers and healthcare professionals. The company's quarterly 10-Q filings provide investors and analysts with updated financial statements, management discussion and analysis, and disclosures about risks and material developments affecting the business.
The upcoming conference presentations may offer additional insights into the company's operational performance and strategic direction as management engages with the investment community.
This article was generated by MarginX from public news on 2026-08-11. It is not investment advice.